Google DeepMind CEO claims goal of "solving all disease" through AI drug discovery
By
Victoria Song
The bagel they save for the regulars. Don't skim, savour.
Summary
This special early edition of The Verge's Optimizer newsletter, tied to Google I/O coverage, contextualizes a bold claim made by Google DeepMind CEO Demis Hassabis during the 2026 I/O keynote. Hassabis stated with a straight face that the company hopes to "reimagine the drug discovery process with the goal of one day solving all disease." The article analyzes and provides context around this ambitious declaration, examining what it means for drug discovery, AI in healthcare, and the broader implications of such a sweeping promise from a major tech executive.
Key quotes
· 2 pulledWe hope to reimagine the drug discovery process with the goal of one day solving all disease.
Toward the end of this year's Google I/O keynote, Google DeepMind CEO Demis Hassabis declared, with a completely deadpan face...
You might also wanna read
Demis Hassabis raises $2.1 billion for Isomorphic Labs to accelerate AI drug discovery
Demis Hassabis, CEO of Google DeepMind and Isomorphic Labs, discusses the company's new $2.1 billion Series B funding round led by Thrive Ca
Demis Hassabis: AI will enable PhD students to match whole lab productivity
Demis Hassabis, Nobel laureate and Google DeepMind co-founder, stated at the 2026 Nobel Prize Dialogue in London that AI will soon enable a

AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
The article discusses recent advancements in AI-driven drug discovery, highlighting two key developments: 1) Analytica 2026, an event focuse
Demis Hassabis Predicts AGI by 2030: Implications for Education and Society
Demis Hassabis, Google DeepMind CEO and Nobel laureate, stated in a Sequoia Capital interview that he expects Artificial General Intelligenc
Review of C2026: Grand Challenges for Predictive Modeling in Drug Discovery
This blog post reviews the C2026 preprint (Grand Challenges for Predictive Modeling in Small Molecule Drug Discovery) published on ChemXriv.
AI accelerates search for motor neurone disease treatments by repurposing existing drugs
Researchers are using AI to accelerate the search for drugs to treat motor neurone disease (MND). By repurposing existing approved drugs, th
